These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7729950

  • 1. Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.
    Versantvoort CH, Withoff S, Broxterman HJ, Kuiper CM, Scheper RJ, Mulder NH, de Vries EG.
    Int J Cancer; 1995 May 04; 61(3):375-80. PubMed ID: 7729950
    [Abstract] [Full Text] [Related]

  • 2. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
    Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC.
    Br J Cancer; 1995 Sep 04; 72(3):535-42. PubMed ID: 7669558
    [Abstract] [Full Text] [Related]

  • 3. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ, Kakehi Y, Yoshida O.
    Int J Urol; 1997 Nov 04; 4(6):583-90. PubMed ID: 9477189
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
    Withoff S, de Vries EG, Keith WN, Nienhuis EF, van der Graaf WT, Uges DR, Mulder NH.
    Br J Cancer; 1996 Dec 04; 74(12):1869-76. PubMed ID: 8980384
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI.
    J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.
    Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J.
    Biochem Biophys Res Commun; 1995 Mar 08; 208(1):345-52. PubMed ID: 7887949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells.
    Wada H, Saikawa Y, Niida Y, Nishimura R, Noguchi T, Matsukawa H, Ichihara T, Koizumi S.
    Exp Hematol; 1999 Jan 08; 27(1):99-109. PubMed ID: 9923448
    [Abstract] [Full Text] [Related]

  • 16. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S, Maxfield LF, Gould CJ, Jones GK, Levy SB.
    Int J Oncol; 2006 Mar 08; 28(3):747-53. PubMed ID: 16465381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer.
    Narasaki F, Matsuo I, Ikuno N, Fukuda M, Soda H, Oka M.
    Anticancer Res; 1996 Mar 08; 16(4A):2079-82. PubMed ID: 8712746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.